Skip to main content

Market Overview

Citi On Accenture: 'Good Execution But Priced In'

Citi On Accenture: 'Good Execution But Priced In'

Despite reporting better-than-expected earnings and strong bookings, Citi expects Accenture Plc (NYSE: ACN) shares to be range-bound and maintains its Neutral rating, as it believes the good execution is already priced in to the stock.

Accenture finished 2016 with a strong 9 percent growth rate in the fourth quarter, driven by Consulting, "the New" (digital, cloud, security), and the products segment.

"Much as we admire and applaud Accenture's track record of performance, we are unwilling to recommend that new money be put to work in a name that delivers ~10 percent EPS CAGR but trades at 20x forward earnings," analyst Ashwin Shirvaikar wrote in a note.

Related Link: Accenture The Best House In A Tough Neighborhood

In fact, Shirvaikar prefers focused emerging technology plays such as EPAM Systems Inc (NYSE: EPAM) or platform plays such as WNS (Holdings) Limited (ADR) (NYSE: WNS) and Amdocs Limited (NASDAQ: DOX).

In the large cap space, the analyst would put his money on Cognizant Technology Solutions Corp (NASDAQ: CTSH) that "deliver comparable total return at a considerably cheaper multiple."

Meanwhile, the positives in Accenture's results include no FX impact in guidance, strong performance and commentary in Financial Services, and dividend increase. On the flip side, the company Indicated decelerating growth for all operating segments.

However, Shirvaikar raised his price target to $120 from $116 on the increased EPS.

Shares of Accenture were seen trading at $122.57, up 0.76 percent, at time of writing. Cognizant was down 14.95 percent at $46.73.

Full ratings data available on Benzinga Pro.

Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!

Latest Ratings for ACN

Apr 2021Deutsche BankMaintainsBuy
Mar 2021BMO CapitalMaintainsMarket Perform
Mar 2021SusquehannaMaintainsPositive

View More Analyst Ratings for ACN
View the Latest Analyst Ratings


Related Articles (CTSH + ACN)

View Comments and Join the Discussion!

Posted-In: Ashwin ShirvaikarAnalyst Color Earnings News Price Target Reiteration Analyst Ratings Tech Best of Benzinga

Latest Ratings

GIKColliers SecuritiesInitiates Coverage On14.0
SANWLake StreetInitiates Coverage On6.0
LILAMorgan StanleyDowngrades15.0
BEJP MorganUpgrades36.0
NEXACredit SuisseUpgrades11.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at